Search research articles
Contact Us
Filters
Showing results (101-110 of 336) with videos related to
Page
of 34
Sort By:
Journal of Oncology Practice
|
November 2, 2010
American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
M Elizabeth H Hammond, Daniel F Hayes, Antonio C Wolff, et al.
Annals of Surgical Oncology
|
March 30, 2002
Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer
Vered Stearns, C Alexander Ewing, Rebecca Slack, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 19, 2021
Improving Oncology-Pathology Collaboration in Resource-Limited Settings: An American Society of Clinical Oncology/College of American Pathologists Initiative
Jose Angel Sanchez, Silvia Portillo, Matthew A Zarka, et al.
Clinical Breast Cancer
|
April 3, 2017
Associations Between Patient and Anthropometric Characteristics and Aromatase Inhibitor Discontinuation
N Lynn Henry, Kelly Speth, Anneleen Lintermans, et al.
Cancer Chemotherapy and Pharmacology
|
November 12, 2005
Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme
Anne F Schott, James M Rae, Kent A Griffith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2014
Reply to R. Bhargava et al and K. Lambein et al
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Journal of Oncology Practice
|
September 4, 2012
Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator
Shannon Wills, Anita Ravipati, Padmaja Venuturumilli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2017
Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement
Laura A Levit, Raymond P Perez, David C Smith, et al.
Breast Cancer Research and Treatment
|
January 10, 2024
Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer
Elizabeth Joyce, Xueting Tao, Vered Stearns, et al.
Breast Cancer Research and Treatment
|
February 2, 2019
Factors influencing the use of extended adjuvant endocrine therapy
Kunal C Kadakia, Kelley M Kidwell, Debra L Barton, et al.
Page
of 34
Search research articles
Search
Showing results (101-110 of 336) with videos related to
Sort By:
Page
of 34
Journal of Oncology Practice
|
November 2, 2010
American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
M Elizabeth H Hammond, Daniel F Hayes, Antonio C Wolff, et al.
Annals of Surgical Oncology
|
March 30, 2002
Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer
Vered Stearns, C Alexander Ewing, Rebecca Slack, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 19, 2021
Improving Oncology-Pathology Collaboration in Resource-Limited Settings: An American Society of Clinical Oncology/College of American Pathologists Initiative
Jose Angel Sanchez, Silvia Portillo, Matthew A Zarka, et al.
Clinical Breast Cancer
|
April 3, 2017
Associations Between Patient and Anthropometric Characteristics and Aromatase Inhibitor Discontinuation
N Lynn Henry, Kelly Speth, Anneleen Lintermans, et al.
Cancer Chemotherapy and Pharmacology
|
November 12, 2005
Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme
Anne F Schott, James M Rae, Kent A Griffith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2014
Reply to R. Bhargava et al and K. Lambein et al
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Journal of Oncology Practice
|
September 4, 2012
Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator
Shannon Wills, Anita Ravipati, Padmaja Venuturumilli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2017
Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement
Laura A Levit, Raymond P Perez, David C Smith, et al.
Breast Cancer Research and Treatment
|
January 10, 2024
Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer
Elizabeth Joyce, Xueting Tao, Vered Stearns, et al.
Breast Cancer Research and Treatment
|
February 2, 2019
Factors influencing the use of extended adjuvant endocrine therapy
Kunal C Kadakia, Kelley M Kidwell, Debra L Barton, et al.
Page
of 34